KalVista Pharmaceuticals, Inc. (KALV) Nonoperating Income (Expense) USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2014 to 2023.
  • KalVista Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending January 31, 2024 was $4.12 M, a 26.9% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending January 31, 2024 was $15.4 M, a 1.16% increase year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $18 M, a 25.9% increase from 2021.
  • KalVista Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2021 was $14.3 M, a 22.2% increase from 2020.
  • KalVista Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2020 was $11.7 M, a 3.42% increase from 2019.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $15.4 M $4.12 M -$1.52 M -26.9% Nov 1, 2023 Jan 31, 2024 10-Q 2024-03-11
Q3 2023 $16.9 M $2.1 M -$1.53 M -42.2% Aug 1, 2023 Oct 31, 2023 10-Q 2023-12-07
Q2 2023 $18.5 M $3.78 M +$502 K +15.3% May 1, 2023 Jul 31, 2023 10-Q 2023-09-07
Q1 2023 $18 M $5.42 M +$2.72 M +101% Feb 1, 2023 Apr 30, 2023 10-K 2023-07-10
Q4 2022 $15.2 M $5.64 M +$1.43 M +33.8% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-11
Q3 2022 $13.8 M $3.63 M -$327 K -8.27% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-07
Q2 2022 $14.1 M $3.27 M -$133 K -3.9% May 1, 2022 Jul 31, 2022 10-Q 2023-09-07
Q1 2022 $14.3 M $2.7 M -$388 K -12.6% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-10
Q4 2021 $14.7 M $4.22 M +$1.61 M +61.6% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-09
Q3 2021 $13.1 M $3.95 M +$1.6 M +67.9% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-08
Q2 2021 $11.5 M $3.41 M -$222 K -6.12% May 1, 2021 Jul 31, 2021 10-Q 2022-09-08
Q1 2021 $11.7 M $3.09 M +$838 K +37.3% Feb 1, 2021 Apr 30, 2021 10-K 2023-07-10
Q4 2020 $10.8 M $2.61 M -$824 K -24% Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-10
Q3 2020 $11.7 M $2.36 M -$1.03 M -30.4% Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-09
Q2 2020 $12.7 M $3.63 M +$1.4 M +63% May 1, 2020 Jul 31, 2020 10-Q 2021-09-09
Q1 2020 $11.3 M $2.25 M -$608 K -21.3% Feb 1, 2020 Apr 30, 2020 10-K 2022-07-07
Q4 2019 $11.9 M $3.43 M +$729 K +27% Nov 1, 2019 Jan 31, 2020 10-Q 2021-03-11
Q3 2019 $11.2 M $3.39 M +$1.8 M +113% Aug 1, 2019 Oct 31, 2019 10-Q 2020-12-10
Q2 2019 $9.38 M $2.23 M +$247 K +12.5% May 1, 2019 Jul 31, 2019 10-Q 2020-09-14
Q1 2019 $9.13 M $2.86 M +$544 K +23.5% Feb 1, 2019 Apr 30, 2019 10-K 2021-07-13
Q4 2018 $8.58 M $2.7 M +$3.59 M Nov 1, 2018 Jan 31, 2019 10-Q 2020-03-10
Q3 2018 $4.99 M $1.59 M +$638 K +67.1% Aug 1, 2018 Oct 31, 2018 10-Q 2019-12-03
Q2 2018 $4.35 M $1.98 M +$1.45 M +277% May 1, 2018 Jul 31, 2018 10-Q 2019-09-09
Q1 2018 $2.9 M $2.31 M +$1.46 M +172% Feb 1, 2018 Apr 30, 2018 10-K 2020-07-01
Q4 2017 $1.44 M -$888 K -$1.36 M -288% Nov 1, 2017 Jan 31, 2018 10-Q 2019-03-14
Q3 2017 $2.8 M $951 K +$221 K +30.3% Aug 1, 2017 Oct 31, 2017 10-Q 2018-12-14
Q2 2017 $2.58 M $525 K -$1.16 M -68.8% May 1, 2017 Jul 31, 2017 10-Q 2018-09-14
Q1 2017 $3.74 M $850 K Feb 1, 2017 Apr 30, 2017 10-K 2019-07-16
Q4 2016 $473 K -$1.39 M -74.6% Nov 1, 2016 Jan 31, 2017 10-Q 2018-03-16
Q3 2016 $730 K Aug 1, 2016 Oct 31, 2016 10-Q 2017-12-14
Q2 2016 $1.68 M +$5.03 M May 1, 2016 Jul 31, 2016 10-Q 2017-09-14
Q4 2015 $1.86 M Nov 1, 2015 Jan 31, 2016 10-Q 2017-03-16
Q2 2015 -$3.35 M -$3.15 M -1581% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-13
Q1 2015 -$283 K -$124 K -78% Jan 1, 2015 Mar 31, 2015 10-Q 2015-05-21
Q2 2014 -$199 K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$159 K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.